Vitamins
A and D kits from SciMed
—Rajan Gupta, founder and president,
SciMed
SciMed Technologies, based in Edmonton, Canada, has developed
diagnostic kits to determine vitamins A and D contents in liquid milk
and infant formula. The company has launched VitaKit A and VitaKit D
into the milk market place. Some dairy processors and
diagnostic labs are currently testing and validating these kits in
pilot projects.
Not all the milk available through various sources of supply contains
the ideal amounts of vitamins A and D. A study done in the
past at Cornell University indicated that almost half the milk on
supermarket shelves was either under or over fortified. This has
clearly created the need for frequent testing and that is the market
need that SciMed is hoping to fulfill through VitaKits A and D.
Rajan Gupta, the founder and president of SciMed, believes that there
is a huge potential for their kits in the Indian market. They
are looking for distribution arrangements in India and it is understood
that some of these discussion are at an advanced stage. “The
kits use two novel technologies developed by SciMed. The first is a
rapid extraction procedure for fat soluble vitamins like A and D and
the second is the two proprietary monoclonal antibodies against
vitamins A and D,” said Gupta.
The rapid extraction process to separate vitamins A and D from milk is
the value proposition that VitaKit offers. While HPLC technologies
could take two days and more reagents, SciMed’s kits reduce
the vitamin extraction step to less than an hour while using
substantially less solvents needed for HPLC. The company
sources indicate that the VitaKit assay method is more accurate when
compared to HPLC. A lab technician using a single VitaKit can analyze
up to 41 samples at a time in less than two hours whereas the HPLC
method would take longer time.
Future plan of SciMed is to move from liquid milk and infant formula
markets to the clinical diagnostic markets. Gupta indicated that they
are developing a low cost lab-on-a-chip (LoC) for Vitamin D3 or
cholecalciferol, which is estimated to be a multi-billion
dollar market. “A LoC diagnostic kit can be used to detect
vitamin D3 deficiencies to prevent 17 varieties of cancer, heart
diseases, stroke diabetes etc. Our vitamin D3 biosensor could be used
to self diagnose vitamin D3 deficiencies at homes, schools
and medical clinics,” added Gupta.
SciMed’s lab-on-a-chip technology platform called SciLOC is
based on proprietary nutri-chips. These are disposable microfluidic
chips that can perform sample handling, separation and detection from
low sample volumes. These chips are inserted into a florescence
detection meter that provides a digital readout and can also wirelessly
transfer data to a computer for further analysis. Talking about future
plans, Gupta said, “Our focus is to develop LoC diagnostic
tools that are portable and can produce results almost instantaneously
at the point-of-need. The global point-of-need market is estimated at
over Rs 59,688 crore last year.”
From the liquid milk and infant formula diagnostic market to the larger
clinical diagnostic market is the way forward for SciMed. Success would
depend not only on product releases but in effectively tapping large
markets like India.
E Abraham Mathew in
Edmonton, Canada